LEE SPENCER S — SEC insider filings
SEC reporting owner CIK 1207134. 40 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 40 filings on record, filed 2020-09-15 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 17 filings — 23,561 shares, $12,878,209 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 70.
- Largest priced transaction: sale of 2,000 shares @ $641.65 ($1,283,300) in CHEMED CORP, filed 2024-04-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CHEMED CORP (CHE) | executive vice president | 40 | — | 17 legs · 23,561 sh · $12,878,209 | 70 |
Insider filings — LEE SPENCER S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | CHEMED CORP (CHE) | Gift (G): 60 @ $0 | EDGAR |
| 2026-11-13 | 4 | CHEMED CORP (CHE) | Sale (S): 1,000 @ $547.61 | EDGAR |
| 2026-11-03 | 4 | CHEMED CORP (CHE) | Sale (S): 920 @ $537.17 | EDGAR |
| 2026-10-22 | 4 | CHEMED CORP (CHE) | Grant/award (A): 7,125 (derivative) @ $512.64 | EDGAR |
| 2026-10-01 | 4 | CHEMED CORP (CHE) | Option exercise (M): 12,099 @ $445.35 · Tax withholding (F): 11,160 @ $508.93 · Option exercise (M): 12,099 (derivative) @ $445.35 | EDGAR |
| 2026-08-24 | 4 | CHEMED CORP (CHE) | Sale (S): 1,000 @ $541.04 | EDGAR |
| 2026-02-17 | 4 | CHEMED CORP (CHE) | Option exercise (M): 499 @ $469.56 · Option exercise (M): 0 @ $469.56 · Tax withholding (F): 154 @ $469.56 · Option exercise (M): 402 (derivative) @ $0 · Option exercise (M): 402 (derivative) @ $0 · Grant/award (A): 960 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | CHEMED CORP (CHE) | Gift (G): 60 @ $0 | EDGAR |
| 2025-10-22 | 4 | CHEMED CORP (CHE) | Grant/award (A): 12,759 (derivative) @ $443.79 | EDGAR |
| 2025-05-19 | 4 | CHEMED CORP (CHE) | Sale (S): 1,500 @ $577.99 | EDGAR |
| 2025-05-08 | 4 | CHEMED CORP (CHE) | Sale (S): 1,500 @ $577.86 | EDGAR |
| 2025-03-03 | 4 | CHEMED CORP (CHE) | Sale (S): 1,326 @ $592.25 | EDGAR |
| 2025-02-18 | 4 | CHEMED CORP (CHE) | Option exercise (M): 824 @ $553.39 · Option exercise (M): 249 @ $553.39 · Tax withholding (F): 342 @ $553.39 · Option exercise (M): 408 (derivative) @ $0 · Option exercise (M): 408 (derivative) @ $0 · Grant/award (A): 822 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | CHEMED CORP (CHE) | Gift (G): 65 @ $0 | EDGAR |
| 2024-11-29 | 4 | CHEMED CORP (CHE) | Sale (S): 732 @ $575.62 | EDGAR |
| 2024-11-22 | 4 | CHEMED CORP (CHE) | Sale (S): 1,000 @ $565.71 | EDGAR |
| 2024-10-23 | 4 | CHEMED CORP (CHE) | Grant/award (A): 9,105 (derivative) @ $597.70 | EDGAR |
| 2024-08-09 | 4 | CHEMED CORP (CHE) | Sale (S): 1,016 @ $580.48 · Option exercise (M): 9,000 @ $413.19 · Tax withholding (F): 7,592 @ $578.31 · Option exercise (M): 9,000 (derivative) @ $413.19 | EDGAR |
| 2024-05-01 | 4 | CHEMED CORP (CHE) | Gift (G): 1,133 @ $0 | EDGAR |
| 2024-04-01 | 4 | CHEMED CORP (CHE) | Sale (S): 2,000 @ $641.65 · Option exercise (M): 13,000 @ $106.59 · Tax withholding (F): 7,080 @ $643.78 · Option exercise (M): 13,000 (derivative) @ $106.59 | EDGAR |
| 2024-02-20 | 4 | CHEMED CORP (CHE) | Option exercise (M): 192 @ $586.49 · Option exercise (M): 288 @ $586.49 · Tax withholding (F): 154 @ $586.49 · Option exercise (M): 308 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0 · Grant/award (A): 742 (derivative) @ $0 | EDGAR |
| 2023-11-27 | 4 | CHEMED CORP (CHE) | Sale (S): 1,000 @ $579.73 | EDGAR |
| 2023-11-13 | 4 | CHEMED CORP (CHE) | Gift (G): 65 @ $0 | EDGAR |
| 2023-11-08 | 4 | CHEMED CORP (CHE) | Sale (S): 1,217 @ $583.85 | EDGAR |
| 2023-10-26 | 4 | CHEMED CORP (CHE) | Grant/award (A): 11,015 (derivative) @ $509.46 | EDGAR |
| 2023-02-22 | 4 | CHEMED CORP (CHE) | Option exercise (M): 519 @ $515.12 · Option exercise (M): 296 @ $515.12 · Tax withholding (F): 313 @ $515.12 · Option exercise (M): 257 (derivative) @ $0 · Option exercise (M): 257 (derivative) @ $0 · Grant/award (A): 804 (derivative) @ $0 | EDGAR |
| 2022-11-16 | 4 | CHEMED CORP (CHE) | Option exercise (M): 8,000 @ $306.70 · Tax withholding (F): 6,268 @ $493.84 · Option exercise (M): 8,000 (derivative) @ $306.70 | EDGAR |
| 2022-11-08 | 4 | CHEMED CORP (CHE) | Sale (S): 2,000 @ $490.09 | EDGAR |
| 2022-11-02 | 4 | CHEMED CORP (CHE) | Grant/award (A): 12,320 (derivative) @ $462.04 | EDGAR |
| 2022-03-08 | 4 | CHEMED CORP (CHE) | Sale (S): 1,054 @ $487.39 | EDGAR |
| 2022-02-23 | 4 | CHEMED CORP (CHE) | Option exercise (M): 669 @ $459.77 · Option exercise (M): 436 @ $459.77 · Tax withholding (F): 532 @ $459.77 · Option exercise (M): 331 (derivative) @ $0 · Option exercise (M): 331 (derivative) @ $0 · Grant/award (A): 816 (derivative) @ $0 | EDGAR |
| 2021-12-13 | 4 | CHEMED CORP (CHE) | Gift (G): 90 @ $0 | EDGAR |
| 2021-11-15 | 4 | CHEMED CORP (CHE) | Option exercise (M): 9,000 @ $231.91 · Tax withholding (F): 6,486 @ $500.02 · Option exercise (M): 9,000 (derivative) @ $231.91 | EDGAR |
| 2021-11-02 | 4 | CHEMED CORP (CHE) | Sale (S): 2,000 @ $489.13 · Grant/award (A): 12,099 (derivative) @ $445.35 | EDGAR |
| 2021-06-17 | 4 | CHEMED CORP (CHE) | Gift (G): 1,982 @ $0 | EDGAR |
| 2021-02-23 | 4 | CHEMED CORP (CHE) | Option exercise (M): 852 @ $491.34 · Option exercise (M): 695 @ $491.34 · Tax withholding (F): 735 @ $491.34 · Option exercise (M): 422 (derivative) @ $0 · Option exercise (M): 422 (derivative) @ $0 · Grant/award (A): 616 (derivative) @ $0 | EDGAR |
| 2020-12-07 | 4 | CHEMED CORP (CHE) | Gift (G): 70 @ $0 · Gift (G): 15 @ $0 | EDGAR |
| 2020-11-06 | 4 | CHEMED CORP (CHE) | Sale (S): 2,153 @ $506.96 · Option exercise (M): 13,600 @ $135.85 · Tax withholding (F): 8,383 @ $509.60 · Option exercise (M): 13,600 (derivative) @ $135.85 | EDGAR |
| 2020-10-30 | 4 | CHEMED CORP (CHE) | Grant/award (A): 10,018 (derivative) @ $471.74 | EDGAR |
| 2020-09-15 | 4 | CHEMED CORP (CHE) | Sale (S): 2,143 @ $495.67 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1207134 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs